Hematology/Coagulation
News on hematology and coagulation testing systems and applications.
Adaptive Biotechnologies Q1 Revenues up 84 Percent, Beat Analyst Estimates
The company attributed its $38.4 million in quarterly revenues to strong progress in both the sequencing and development services arms of its business.
Bio-Rad Q4 Revenues Down 1 Percent, Beat Estimates
The company's full-year revenues rose 6 percent and were slightly higher than the consensus Wall Street estimate.
FDA Approves Progenika MDx Assay for Blood Compatibility
The ID Core XT is the second molecular assay approved by the FDA for use in transfusion medicine and the first to report genotypes as final results.
Danaher Q2 Revenues Rise 10 Percent, Beating Analyst Estimates
The company's Life Sciences segment was up 17 percent year over year, while its Diagnostics business grew 8 percent.
FDA Clears Roche Factor II, Factor V Gene Mutation Test for Inherited Thrombophilia
The test reduces hands-on time by enabling labs to simultaneously assess Factor II and Factor V gene mutations from a single patient sample, Roche said.
Jul 21, 2017
Streck Names Distributor in Kuwait
Jun 2, 2017
Streck, Nordic BioSite Ink Distribution Deal
May 19, 2017
Jan 31, 2017
Hologic Completes Divestiture of Grifols for $1.85B
Jul 18, 2016
T2 Biosystems, Bayer Ink Hemostasis R&D Deal
Apr 11, 2016